Cargando…
Modulation of the P-Glycoproein-Mediated Intestinal Secretion of Glibenclamide: In Vitro and In Vivo Assessments
The everted gut sac method was used to assess the role of the P-glycoprotein (P-gp) on the intestinal secretion of glibenclamide, a prototype of drug used to treat diabetic mellitus. The study included the evaluation of a P-gp modulator carbamazepine used at equimolar doses in the rat. Furthermore,...
Autores principales: | Srirangam, P, Vidya, Sagar J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019377/ https://www.ncbi.nlm.nih.gov/pubmed/21264098 http://dx.doi.org/10.4103/0975-1483.71632 |
Ejemplares similares
-
Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells
por: de Sant’Anna, Juliane Rocha, et al.
Publicado: (2015) -
Design, evaluation and in vitro - in vivo correlation of glibenclamide buccoadhesive films
por: Prasanna, R Indira, et al.
Publicado: (2012) -
Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats
por: Prashanth, S., et al.
Publicado: (2011) -
In Vitro and In Vivo Quality Evaluation of Glibenclamide Tablets Marketed in Addis Ababa, Ethiopia
por: Kassahun, Haile, et al.
Publicado: (2018) -
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome
por: Scala, Rosa, et al.
Publicado: (2020)